TABLE 3.
Individual study estimates of the adjusted odds ratios of active tuberculosis comparing DM prevalence in TB cases and non‐TB controls in sub‐Saharan Africa, stratified by HIV status
| HIV uninfected | HIV infected | ||
|---|---|---|---|
| First author, (year) | Method of DM diagnosis | Adjusted OR of active TB (95% CI) | Adjusted OR of active TB (95% CI) |
| Kubjane et al. (2020) [21] | FBG, HbA1c, self‐reported | 3.5 (1.2–9.8) | 2.4 (1.0–5.3) |
| Boillat‐Blanco et al. (2016) [22] |
FCG OGTT HbA1c |
8.8 (2.1–36.6) 3.8 (1.4–10.5) 19.3 (6.1–61.0) |
17.1 (1.6–179.4) 3.8 (1.0–15.3) 4.7 (1.1–20.8) |
| Bailey et al. (2016) [27] | RBG | 1.90 (0.89–4.04) | 5.34 (1.56–18.23) |
| Faurholt‐Jepsen et al. (2011) [20] | FBG and OGTT |
2.14 (1.32–3.46) a 4.23 (1.54–11.57) b |
2.05 (0.68–6.19) a 0.14 (0.01–1.81) b |
Abbreviations: DM, diabetes mellitus; TB, tuberculosis; FBG, fasting blood glucose; HbA1c, glycosylated haemoglobin; FCG, fasting capillary glucose; OGTT, oral glucose tolerance test; RBG, random blood glucose.
This estimate resulted from model 1 that adjusted for age, sex, HIV and socio‐demography.
This estimate resulted from model 2 that additionally adjusted for serum alpha‐1‐acid glycoprotein levels.